ATL/Interspec merger approved

Article

The merger of ultrasound vendorsATL and Interspec was approved this week by the shareholders ofboth companies. The companies announced the merger in February(SCAN 2/16/94). Under the terms of the merger, Interspec will become a whollyowned subsidiary

The merger of ultrasound vendorsATL and Interspec was approved this week by the shareholders ofboth companies. The companies announced the merger in February(SCAN 2/16/94).

Under the terms of the merger, Interspec will become a whollyowned subsidiary of ATL through an exchange of one share of Interspecstock for 0.413 shares of ATL stock. The acquisition creates anultrasound company with combined revenues of approximately $360million and an installed base of over 20,000 systems.

Interspec chief Edward Ray will continue as president of theAmbler, PA-based company and will join ATL's board of directors.ATL is based in Bothell, WA.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.